HOSPITAL SERIES
Zhongshan Hospital in Shanghai: Liver Cancer and Cardiovascular Care
Zhongshan Hospital, Fudan University, is one of Shanghai’s major teaching hospitals. Founded in 1937, it has developed substantial expertise in liver cancer and cardiovascular disease, supported by specialist institutes and a long tradition of clinical research.

A Shanghai Teaching Hospital Founded in 1937
Established in commemoration of Sun Yat-sen, Zhongshan Hospital is affiliated with Fudan University in Shanghai. It combines comprehensive hospital care with specialist research institutes and medical training.
Liver cancer and cardiovascular disease are two of its most prominent fields. Shanghai’s official international patient directory also highlights renal and pulmonary medicine. These areas sit within a broad hospital structure, rather than a clinic dedicated to a single procedure.
Liver Cancer: From Surgical Care to Translational Research
The Liver Cancer Institute of Fudan University is based at Zhongshan. The hospital’s liver surgery and transplantation specialists work on hepatocellular carcinoma, the liver cancer discussed in much of the institute’s published research.
Their research includes questions about how tumors develop, recur and respond to treatment. A 2024 Cancer Cell review with Zhongshan authors examines precision treatment for advanced hepatocellular carcinoma—an approach that seeks to match treatment more closely to the biology of the disease.
This combination of a specialist institute and a surgical team provides a substantial base for assessing liver cancer. A specific review may still require input from medical oncology, radiology or pathology, depending on the question.
Cardiovascular Medicine and Clinical Teaching
Zhongshan also houses the Shanghai Institute of Cardiovascular Diseases. Its cardiology program combines clinical practice, research and the education of future physicians.
A May 2026 Fudan report follows the cardiology teaching team as it discusses coronary intervention, heart valves and the broader effects of vascular disease. The article describes how hospital clinicians connect practical experience with medical education.
In July 2026, Fudan reported a national science and technology award for a Zhongshan heart-failure project led by Sun Aijun, with guidance and participation from the cardiology leadership. The project studied disease mechanisms, earlier diagnosis and treatment technologies.
Featured Specialist: Fan Jia

Fan Jia is a liver tumor and transplantation specialist and a member of the Chinese Academy of Sciences. Fudan’s May 2025 biography identifies him as Zhongshan Hospital’s honorary president. His professional work spans liver tumor surgery, basic science and research that connects laboratory findings with clinical care.
Fan is among the authors of the 2024 Cancer Cell review on precision treatment for advanced hepatocellular carcinoma. The paper’s Zhongshan affiliation connects his academic work with the hospital’s liver surgery and transplantation program. It is a review of research, rather than a trial demonstrating an individual surgeon’s outcomes.
International Services and Specialist Second Opinions
Shanghai’s official patient directory lists English, French and Japanese service languages for Zhongshan, as well as multidisciplinary consultations and outpatient chemotherapy. It also lists remote consultation among the services described.
These published services provide a starting point for international enquiries. They do not confirm the format, eligibility or availability of a particular overseas records review. China Heal Plus currently coordinates written second opinions and confirms the specialist, required materials, language arrangements and report scope for each accepted request.
Sources: [6]
Sources and data notes
- Fudan University: affiliated hospitals and Zhongshan identity
Official university directory, including historical 2013 activity; current capacity counts are not reproduced. Rechecked 8 October 2026.
- Fudan: Fan Jia profile
Published 30 May 2025; identifies honorary president, liver-tumour/transplant expertise and academy membership. Rechecked 8 October 2026.
- PubMed: precision treatment in advanced hepatocellular carcinoma
Cancer Cell, 2024; indexed as a review. Author Jia Fan and Zhongshan affiliation checked; no individual clinical outcome inferred. Rechecked 8 October 2026.
- Fudan: Ge Junbo and the Zhongshan cardiology teaching team
Published 16 May 2026; supports current institutional role and academic context. National intervention totals are not attributed to this doctor. Rechecked 8 October 2026.
- Fudan: Zhongshan heart-failure research award
Published 10 July 2026 about the 8 July award announcement; project led by Sun Aijun, with Ge Junbo guidance and participation. Rechecked 8 October 2026.
- Shanghai Municipal Government: Zhongshan Hospital international services
Municipal patient information published under a 14 October 2024 URL and sourced to the Shanghai Municipal Commission of Health. Rechecked 8 October 2026; listed services do not guarantee an individual overseas remote appointment.
Published by China Heal Plus. General information, not an individual medical assessment. Inclusion of a hospital or physician does not imply a partnership or endorsement of our service.